World Of Taxonomy
68135-020Level 3

NAGLAZYME (galsulfase)

**Product type:** Human Prescription Drug

**Active ingredient:** GALSULFASE

**Strength:** 5 mg/5mL

**Dosage form:** Solution

**Route:** Intravenous

**Labeler:** BioMarin Pharmaceutical Inc.

**Marketing category:** BLA (BLA125117)

**Pharmacologic class:** Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]

GET/api/v1/systems/ndc_fda/nodes/68135-020
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.